BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Anatol P, Danuta P, Janusz D, Bozena P. Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol 2005; 11(19): 2949-2952 [PMID: 15902734 DOI: 10.3748/wjg.v11.i19.2949]
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2949.htm
Number Citing Articles
1
Xandra Volkmann, Markus Cornberg, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Klaus Schulze-Osthoff, Heike Bantel. Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionHepatology 2006; 43(6): 1311 doi: 10.1002/hep.21186
2
Dale L. Barnard, Craig W. Day, Kevin Bailey, Matthew Heiner, Robert Montgomery, Larry Lauridsen, Scott Winslow, Justin Hoopes, Joseph K.-K. Li, Jongdae Lee, Dennis A. Carson, Howard B. Cottam, Robert W. Sidwell. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinAntiviral Research 2006; 71(1): 53 doi: 10.1016/j.antiviral.2006.03.001
3
YUN-FEI LI, QIN-ZHANG WANG, TAO-TAO ZHANG, LEI LI, JIANG-PING WANG, GUO-FU DING, DA-LIN HE. Low dose of interferon-α improves the clinical outcomes of docetaxel in patients with castration-resistant prostate cancer: A pilot studyOncology Letters 2014; 7(1): 125 doi: 10.3892/ol.2013.1653
4
Emad F. Eskander, Ahmed A. Abd-Rabou, Mervat S. Mohamed, Shaymaa M. M. Yahya, Olfat G. Shaker. Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?Indian Journal of Clinical Biochemistry 2012; 27(4): 344 doi: 10.1007/s12291-012-0219-6
5
Adel Abdel-Moneim, Osama M. Ahmed, Sanaa M. Abd El-Twab, Mohamed Y. Zaky, Lamiaa N. Bakry. Prophylactic effects of Cynara scolymus L. leaf and flower hydroethanolic extracts against diethylnitrosamine/acetylaminoflourene-induced lung cancer in Wistar ratsEnvironmental Science and Pollution Research 2021; 28(32): 43515 doi: 10.1007/s11356-021-13391-x
6
Evangelos Cholongitas, George V. Papatheodoridis, Emanuel K. Manesis, Kaliopi Petraki, Dina Tiniakos, Stephanos J. Hadziyannis. Effect of antiviral therapy on the immunohistochemical expression of bcl‐xL and bax protein in patients with HBeAg‐negative chronic hepatitis BJournal of Medical Virology 2011; 83(7): 1165 doi: 10.1002/jmv.21780
7
Ann M. Van Wie. Hepatitis C and interferon-associated retinopathy: A case reportOptometry - Journal of the American Optometric Association 2011; 82(12): 739 doi: 10.1016/j.optm.2010.11.016
8
Olfat G. Shaker, Emad F. Eskander, Shaymaa M.M. Yahya, Mervat S. Mohamed, Ahmed A. Abd-Rabou. Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patientsClinica Chimica Acta 2011; 412(7-8): 593 doi: 10.1016/j.cca.2010.12.009
9
Gergely Oswald, Kousi Alzoubi, Majed Abed, Florian Lang. Stimulation of Suicidal Erythrocyte Death by RibavirinBasic & Clinical Pharmacology & Toxicology 2014; 114(4): 311 doi: 10.1111/bcpt.12165
10
Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 InfectionInternational Journal of Molecular Sciences 2015; 16(2): 3213 doi: 10.3390/ijms16023213
11
Mervat M. Sultan, Ahmed El-Refaie, Ayat R. Abdallah, Eman Abdelsameea, Maha M. El-Sabaawy. Expansion of intrahepatic lymphocytes expressing PD-1 and bcl-2 in chronic hepatitis CEgyptian Journal of Pathology 2018; 38(1): 105 doi: 10.1097/01.XEJ.0000542232.60893.db